PFIZER.NS vs. JNJ
Compare and contrast key facts about Pfizer Limited (PFIZER.NS) and Johnson & Johnson (JNJ).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: PFIZER.NS or JNJ.
Key characteristics
| PFIZER.NS | JNJ | |
|---|---|---|
| YTD Return | 43.60% | 8.08% |
| 1Y Return | 59.26% | 4.29% |
| 3Y Return (Ann) | 1.26% | 3.05% |
| 5Y Return (Ann) | 15.81% | 7.76% |
| 10Y Return (Ann) | 15.81% | 7.49% |
| Sharpe Ratio | 2.63 | 0.27 |
| Daily Std Dev | 22.73% | 15.32% |
| Max Drawdown | -59.70% | -52.60% |
| Current Drawdown | -3.56% | -4.31% |
Fundamentals
| PFIZER.NS | JNJ | |
|---|---|---|
| Market Cap | ₹278.77B | $398.45B |
| EPS | ₹132.84 | $6.60 |
| PE Ratio | 45.87 | 25.08 |
| Total Revenue (TTM) | ₹22.25B | $86.58B |
| Gross Profit (TTM) | ₹12.52B | $59.79B |
| EBITDA (TTM) | ₹7.74B | $33.37B |
Correlation
The correlation between PFIZER.NS and JNJ is 0.05, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
PFIZER.NS vs. JNJ - Performance Comparison
In the year-to-date period, PFIZER.NS achieves a 43.60% return, which is significantly higher than JNJ's 8.08% return. Over the past 10 years, PFIZER.NS has outperformed JNJ with an annualized return of 15.81%, while JNJ has yielded a comparatively lower 7.49% annualized return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
PFIZER.NS vs. JNJ - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Pfizer Limited (PFIZER.NS) and Johnson & Johnson (JNJ). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
PFIZER.NS vs. JNJ - Dividend Comparison
PFIZER.NS's dividend yield for the trailing twelve months is around 0.57%, less than JNJ's 2.94% yield.
| TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
PFIZER.NS Pfizer Limited | 0.57% | 0.82% | 1.47% | 0.10% | 6.46% | 0.53% | 0.70% | 1.70% | 0.82% | 0.53% | 0.00% | 32.92% |
JNJ Johnson & Johnson | 2.94% | 3.00% | 2.52% | 2.45% | 2.53% | 2.57% | 2.74% | 2.38% | 2.73% | 2.87% | 2.64% | 2.83% |
Drawdowns
PFIZER.NS vs. JNJ - Drawdown Comparison
The maximum PFIZER.NS drawdown since its inception was -59.70%, which is greater than JNJ's maximum drawdown of -52.60%. Use the drawdown chart below to compare losses from any high point for PFIZER.NS and JNJ. For additional features, visit the drawdowns tool.
Volatility
PFIZER.NS vs. JNJ - Volatility Comparison
Pfizer Limited (PFIZER.NS) has a higher volatility of 6.65% compared to Johnson & Johnson (JNJ) at 3.28%. This indicates that PFIZER.NS's price experiences larger fluctuations and is considered to be riskier than JNJ based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
PFIZER.NS vs. JNJ - Financials Comparison
This section allows you to compare key financial metrics between Pfizer Limited and Johnson & Johnson. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities